Cargando…

Negative regulation of CD44st by miR-138-5p affects the invasive ability of breast cancer cells and patient prognosis after breast cancer surgery

OBJECTIVE: To investigate how the negative regulation of CD44st by miR-138-5p affects the invasive ability of breast cancer cell lines and prognosis in postoperative breast cancer patients. METHODS: RT-PCR, qRT-PCR, and western blot assays were used to detect the expression of CD44s, CD44v6, and CD4...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jian, Fang Xin, Bao, Peng Xiao, Li, Wang Fu, Cui, Yan Hai, Hong, Hang Guan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037889/ https://www.ncbi.nlm.nih.gov/pubmed/36964570 http://dx.doi.org/10.1186/s12885-023-10738-0

Ejemplares similares

Effect of CD44st and HER2 expression on the postoperative prognosis of breast cancer patients
por: Chen, Dan Dan, et al.
Publicado: (2019)

A correlation study of the expression of HA-CD44st and HER-2 in breast cancer
por: Ying Zhi, Lu, et al.
Publicado: (2018)

CD44(+)/CD24(−) phenotype predicts a poor prognosis in triple-negative breast cancer
por: Wang, Hui, et al.
Publicado: (2017)

CD44 Variant Isoform Expression and Breast Cancer Prognosis
por: Tokue, Yutaka, et al.
Publicado: (1998)

Predictive Value of CD44 for Prognosis in Patients with Breast Cancer
por: Roosta, Yousef, et al.
Publicado: (2020)

CD44 Targeted Nanomaterials for Treatment of Triple-Negative Breast Cancer
por: Nabil, Ghazal, et al.
Publicado: (2021)

Downregulation of CD44 reduces doxorubicin resistance of CD44(+)CD24(−) breast cancer cells
por: Van Phuc, Pham, et al.
Publicado: (2011)

DACH1 suppresses breast cancer as a negative regulator of CD44
por: Xu, Hanxiao, et al.
Publicado: (2017)

Phototheranostics of CD44-positive cell populations in triple negative breast cancer
por: Jin, Jiefu, et al.
Publicado: (2016)

MicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44
por: Yeh, Margaret, et al.
Publicado: (2021)

Disruption of the pentraxin 3/CD44 interaction as an efficient therapy for triple‐negative breast cancers
por: Hsiao, Yu‐Wei, et al.
Publicado: (2022)

Dimensional Analysis of CD44(High) CD24(Low) and Ki67 in Triple Negative Breast Cancer
por: Tan, Betty, et al.
Publicado: (2019)

CD44 rs13347 C>T polymorphism predicts breast cancer risk and prognosis in Chinese populations
por: Jiang, Lan, et al.
Publicado: (2012)

CD44 Gene Polymorphisms in Breast Cancer Risk and Prognosis: A Study in North Indian Population
por: Tulsyan, Sonam, et al.
Publicado: (2013)

CD44 increases the efficiency of distant metastasis of breast cancer
por: McFarlane, Suzanne, et al.
Publicado: (2015)

Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis
por: Xu, Hanxiao, et al.
Publicado: (2016)

CD44 activation state regulated by the CD44v10 isoform determines breast cancer proliferation
por: Guo, Qian, et al.
Publicado: (2021)

A Systematic Review to Clarify the Prognostic Values of CD44 and CD44(+)CD24(-) Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead
por: Abdoli Shadbad, Mahdi, et al.
Publicado: (2021)

Expression of miR-21 and miR-138 in colon cancer and its effect on cell proliferation and prognosis
por: You, Changxuan, et al.
Publicado: (2019)

Evaluation of CD44+/CD24- and Aldehyde Dehydrogenase Enzyme Markers in Cancer Stem Cells as Prognostic Indicators for Triple-Negative Breast Cancer
por: Escudero Mendez, Lisbeth, et al.
Publicado: (2022)

CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer
por: Xu, Hanxiao, et al.
Publicado: (2016)

The role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7
por: Fang, Xin Jian, et al.
Publicado: (2011)

Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer
por: Wu, Cheng-Lin, et al.
Publicado: (2015)

Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer
por: Krishnamachary, Balaji, et al.
Publicado: (2012)

CD44v9 as a poor prognostic factor of triple-negative breast cancer treated with neoadjuvant chemotherapy
por: Tokunaga, Eriko, et al.
Publicado: (2018)

In Situ Identification of CD44+/CD24− Cancer Cells in Primary Human Breast Carcinomas
por: Perrone, Giuseppe, et al.
Publicado: (2012)

Association of human breast cancer CD44(-)/CD24(-) cells with delayed distant metastasis
por: Qiao, Xinbo, et al.
Publicado: (2021)

Selective killing of breast cancer cells expressing activated CD44 using CD44 ligand-coated nanoparticles in vitro and in vivo
por: Yang, Cuixia, et al.
Publicado: (2015)

Can CD44+/CD24- Tumor Cells Be Used to Determine the Extent of Breast Cancer Invasion Following Neoadjuvant Chemotherapy?
por: Wu, Hong, et al.
Publicado: (2011)

CD44-Receptor Targeted Gold-Doxorubicin Nanocomposite for Pulsatile Chemo-Photothermal Therapy of Triple-Negative Breast Cancer Cells
por: Kalyane, Dnyaneshwar, et al.
Publicado: (2022)

Next Generation CD44v6-Specific CAR-NK Cells Effective against Triple Negative Breast Cancer
por: Raftery, Martin J., et al.
Publicado: (2023)

Anticancer Analysis of CD44 Targeted Cyclosporine Loaded Thiolated Chitosan Nanoformulations for Sustained Release in Triple-Negative Breast Cancer
por: Abduh, Maisa Siddiq
Publicado: (2023)

In vivo monitoring of CD44(+) cancer stem-like cells by γ-irradiation in breast cancer
por: KIM, MI HYUN, et al.
Publicado: (2016)

CD24 Overexpression Is Associated with Poor Prognosis in Luminal A and Triple-Negative Breast Cancer
por: Kwon, Mi Jeong, et al.
Publicado: (2015)

Cobalt ferrite nanoparticle for the elimination of CD133+CD44(+) and CD44(+)CD24(−), in breast and skin cancer stem cells, using non-ionizing treatments
por: Khalili Najafabad, Bahareh, et al.
Publicado: (2023)

MicroRNA-138 is a Prognostic Biomarker for Triple-Negative Breast Cancer and Promotes Tumorigenesis via TUSC2 repression
por: Nama, Srikanth, et al.
Publicado: (2019)

Tumorigenic and Metastatic Role of CD44(−/low)/CD24(−/low) Cells in Luminal Breast Cancer
por: Vikram, Rajeev, et al.
Publicado: (2020)

Knockdown of ALDH1A3 reduces breast cancer stem cell marker CD44 via the miR-7-TGFBR2-Smad3-CD44 regulatory axis
por: Pan, Meng, et al.
Publicado: (2021)

Clinical features and prognosis of triple-negative breast cancer
por: Sanz, M Izquierdo, et al.
Publicado: (2009)

T-cadherin is associated with prognosis in triple-negative breast cancer
por: Kong, De-Di, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cqvaujb84bfpsnontneroncq5e